AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Cosmos Health Inc. has finalized a $300 million financing agreement with a U.S.-based institutional investor, structured as senior secured convertible promissory notes. The company will allocate at least 72.5% of the net proceeds from each tranche to a long-term Ethereum (ETH) treasury. This allocation will support its
strategy and broader operational goals, including product innovation, U.S. manufacturing expansion, and blockchain-based advancements in supply chain traceability and consumer engagement [1].The ETH will be stored and staked through BitGo Trust Company, which will also provide institutional-grade custody and insurance coverage for the assets [2]. According to the company’s CEO, Greg Siokas, the initiative is a strategic, long-term commitment to leverage Ethereum for value creation and operational efficiency. The company is also exploring yield-generating opportunities tied to its ETH holdings [3].
The move marks a significant milestone as one of the first U.S. healthcare companies to integrate crypto into its capital structure. Following the announcement, Cosmos Health’s stock price surged over 16% in the days that followed [4]. However, the strategy has not been without skepticism. Critics have raised concerns about Ethereum’s price volatility and the implications of funding the initiative through convertible notes, which may reflect limited operational cash flow [5].
Institutional investors have responded with mixed signals. While some, like Armistice Capital, have added the company’s shares to their portfolio, others, including Susquehanna and Two Sigma, have liquidated their holdings [6]. Despite these concerns,
has emphasized that the digital asset strategy is a core component of its long-term vision. The company is actively developing blockchain-based innovations in healthcare and remains committed to integrating digital assets into its business model [7].The firm’s collaboration with BitGo has also reinforced its credibility with institutional partners [8]. The broader trend of corporate crypto adoption is evident in the actions of other firms. For instance, Satsuma Technology, a UK-listed firm, raised $218 million through a convertible loan offering and accepted $125 million in Bitcoin as part of its AI development strategy.
, listed in New York, has also expanded its crypto treasury by purchasing $4.9 million worth of SOL and launching its own validator [1].While Cosmos Health’s move signals growing interest in digital assets among corporations, risks remain, particularly around execution timelines and market volatility [9]. The initiative, however, highlights the increasing acceptance of crypto as a tool for value creation and innovation in the corporate sector.
Quickly understand the history and background of various well-known coins

Dec.02 2025

Dec.02 2025

Dec.02 2025

Dec.02 2025

Dec.02 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet